This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
Following finalized regulations from the Florida Department of Health for the sale of edible cannabis products, Trulieve will introduce edibles in its medical cannabis dispensaries across the state.
The U.S. Food and Drug Administration has approved Epidiolex (cannabidiol) oral solution for the treatment of seizures associated with tuberous sclerosis complex, a genetic disorder characterized by growth of numerous noncancerous tumors.
Today, medical cannabis is approved for use in 33 U.S. states plus the District of Columbia, and several other states have medical or recreational cannabis legalization on the fall election ballot.
For many consumers dealing with a variety of medical conditions, cannabis is essential medicine. And the market for cannabis-infused foods and beverages shows significant potential for growth.
The legal cannabis market is the hottest industry in the U.S. By 2023, Brightfield Group estimates that the total U.S. market will reach $22.7 billion, with a CAGR of 20 percent from 2019 to 2023.
While records of medical and therapeutic use of cannabis go back thousands of years, several points in history proved instrumental to furthering the ongoing body of research.
Hop Chronic IPA will only be available at licensed dispensaries and only to people who have a medical recommendation for the use of cannabis. Hop Chronic IPA will be available in a variety of THC and CBD potencies.